Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGHT.L Regulatory News (GHT)

  • There is currently no data for GHT

Director's Dealing

28 Mar 2019 07:00

RNS Number : 2528U
Gresham Technologies PLC
28 March 2019
 

RNS

 

28 March 2019

Gresham Technologies plc

Director's Dealing

Gresham Technologies plc (LSE: "GHT" or the "Company") announces that on 27 March 2019, Andy Balchin, non-executive director of the Company, purchased 8,233 ordinary shares in the capital of the Company ("Ordinary Shares") at a price of 89.9 pence per Ordinary Share.

The Ordinary Shares, being equivalent to 0.01 per cent. of GHT's voting share capital, represents Andy's only holding in the Company.

Enquiries

Gresham Technologies plc

+44 (0) 207 653 0200

Ian Manocha

Tom Mullan

N+1 Singer (Joint Broker)

+44 (0) 207 496 3000

Shaun Dobson / Lauren Kettle (Corporate Finance)

Tom Salvesen (Corporate Broking)

Cantor Fitzgerald Europe (Joint Broker)

+44 (0) 207 894 7000

Philip Davies / Richard Salmond

Note to editors

Gresham Technologies plc is a leading software and services company that specialises in providing real-time data integrity and control solutions. Listed on the main market of the London Stock Exchange (GHT.L) and headquartered in the City of London, its customers include some of the world's largest financial institutions, all of whom are served locally from offices located in Europe, North America and Asia Pacific.

Gresham's award-winning Clareti software platform has been designed to provide financial institutions with complete certainty in their data processing. Clareti is a highly flexible and fully scalable platform for ensuring the integrity of data across an enterprise. It is designed to address today's most challenging financial control, risk management, data governance and regulatory compliance problems.

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

Name

Andy Balchin

2

Reason for the notification

a)

Position/status

Non-Executive Director

b)

Initial notification /Amendment

Initial

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Gresham Technologies plc

b)

LEI

213800F71LW7L4Y7QL29

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

Ordinary shares of 5 pence each

 

 

GB0008808825

 

b)

Nature of the transaction

Purchase

c)

 

Price(s) and volume(s)

 

Price

Volume

89.9p

8,233

d)

 

Aggregated information

 

- Aggregated volume

 

- Price

 

 

 

n/a

 

e)

Date of the transaction

27 March 2019

f)

Place of the transaction

London Stock Exchange

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHUBAURKVAOUUR
Date   Source Headline
10th Apr 20241:54 pmGNWForm 8.3 - Gresham Technologies Plc
10th Apr 202411:34 amRNSForm 8.3 - Gresham Technologies plc
10th Apr 202411:31 amGNWForm 8.3 - [ GRESHAM TECHNOLOGIES PLC - 09 04 2024] - (CGAML)
10th Apr 202411:12 amRNSForm 8.3 - Gresham Technologies PLC
10th Apr 202410:39 amRNSForm 8.5 (EPT/RI)
10th Apr 20247:53 amPRNForm 8.3 - Gresham Technologies Plc
9th Apr 20241:56 pmRNSForm 8.3 - Gresham Technologies PLC
9th Apr 20247:00 amRNSOffer for Gresham Technologies plc
13th Feb 20247:00 amRNSStrategic Contract Win
1st Feb 202412:08 pmRNSHolding(s) in Company
19th Jan 202412:54 pmRNSHolding(s) in Company
17th Jan 20249:00 amRNSAppointment of Chief Technology Officer
11th Jan 20247:01 amRNSBoard Appointment
11th Jan 20247:00 amRNSTrading Update and Notice of Results
23rd Nov 20232:30 pmRNSPDMR Dealings
20th Nov 20235:07 pmRNSHolding(s) in Company
17th Nov 20237:00 amRNSTrading Update
19th Oct 20237:00 amRNSInvestor Presentation on Floe banking solution
17th Oct 20237:00 amRNSChair Appointment
6th Oct 20231:45 pmRNSExercise of Options and TVR
2nd Oct 20232:04 pmRNSHolding(s) in Company
25th Aug 20233:59 pmRNSHolding(s) in Company
17th Aug 20237:00 amRNSUSD1.6m contract win with Tier 1 asset manager
27th Jul 202312:00 pmRNSExercise of Options and TVR
26th Jul 20237:00 amRNSInterim Report Announcement and Board Changes
3rd Jul 20237:00 amRNSUSD1.6m new customer win in investment management
29th Jun 20237:00 amRNSInvestor Presentation
24th May 20232:16 pmRNSHolding(s) in Company
23rd May 20234:37 pmRNSResult of Annual General Meeting
23rd May 20237:00 amRNSAGM Statement and Notice of Results
5th Apr 20237:00 amRNSDirector Equity Awards
3rd Apr 20237:00 amRNSNotice of AGM and Dividend Timetable
29th Mar 20237:00 amRNSExercise of Options and Issue of Shares to EBT
24th Mar 202312:45 pmRNSHolding(s) in Company
23rd Mar 20235:00 pmRNSHolding(s) in Company
14th Mar 20237:00 amRNSFinal Results
10th Mar 202310:17 amRNSHolding(s) in Company
14th Feb 20237:00 amRNSNotice of Results and Presentations
10th Jan 20237:00 amRNSTrading Update
30th Dec 20227:00 amRNSUSD 1.3m Clareti contract win with Tier 1 bank
19th Dec 20227:00 amRNSUSD 1.9m new customer win in investment management
13th Dec 20225:33 pmRNSHolding(s) in Company
13th Dec 20227:00 amRNSTrading update
7th Dec 20221:17 pmRNSHolding(s) in Company
2nd Nov 20224:47 pmRNSHolding(s) in Company
5th Oct 20222:16 pmRNSExercise of Options
4th Oct 20227:00 amRNSTrading Update
27th Sep 20227:00 amRNSClimate-related financial disclosure
12th Sep 20227:00 amRNSNotice of Capital Markets Day
8th Aug 20227:00 amRNSExercise of Options

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.